NeuroHeal Biomedicals: a new technology-based company of the UAB to develop a new treatment for peripheral nerve damage

  • NeuroHeal Biomedicals will advance the development of a new drug to restore peripheral nerve well function. The objective of the company is to initiate clinical trials in humans within two years
  • The research team led by Dr. Caty Casas, from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB), has created the company NeuroHeal Biomedicals to develop a new neuroprotective treatment that also accelerates the regeneration of damaged peripheral nerves.



Click here for more information.

Post comment

Your email address will not be published. Required fields are marked *

© Transautophagy